Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Satellos Bioscience News

    0,30 € -6,25% -0,02 €
    08:02:42 Uhr Frankfurt aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3CSSM
    ISIN: CA80401L3083
    US-Symbol: MSCLF
    Typ: Aktie

    Satellos Bioscience News

    22.03.21 - PR Newswire
    IIROC Trading Halt - ICO
    IIROC Trading Halt - ICO Canada NewsWire
    25.02.21 - PR Newswire
    IIROC Trading Resumption - ICO
    IIROC Trading Resumption - ICO Canada NewsWire
    25.02.21 - PR Newswire
    IIROC Trading Halt - ICO
    IIROC Trading Halt - ICO Canada NewsWire
    13.07.20 - Newsfile
    iCo Therapeutics Announces First Quarter 2020 Financial Results
    Vancouver, British Columbia--(Newsfile Corp. - July 13, 2020) - iCo Therapeutics (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or the "Company"), today reported financial results for the ...
    29.05.20 - Newsfile
    iCo Therapeutics Inc. Announces Q1 Interim Filing Update
    Vancouver, British Columbia--(Newsfile Corp. - May 29, 2020) - iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or "the Company") is providing an update on the status of ...
    19.05.20 - Newsfile
    iCo Therapeutics Announces 2019 Year End Financial Results
    Vancouver, British Columbia--(Newsfile Corp. - May 19, 2020) -   iCo Therapeutics (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or the "Company"), today reported financial results for the year ...
    27.04.20 - Newsfile
    iCo Therapeutics Inc. Announces Annual Filing Update
    Vancouver, British Columbia--(Newsfile Corp. - April 27, 2020) - iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or "the Company") is providing an update on the status of ...
    15.04.20 - Newsfile
    iCo Therapeutics Inc. Announces Oral Amphotericin B (iCo 019) Update / Appointment of Kishor Wasan as Director of Research
    Vancouver, British Columbia--(Newsfile Corp. - April 15, 2020) -  iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or the "Company") announced today the successful ...
    09.03.20 - Newsfile
    iCo Therapeutics Announces Leadership Changes
    Vancouver, British Columbia--(Newsfile Corp. - March 9, 2020) - iCo Therapeutics Inc.  (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or the "Company") announces that Andrew Rae, MBA, has ...
    25.02.20 - Newsfile
    iCo Therapeutics Successfully Concludes Phase 1b Clinical Study Announces Positive Primary End Point for Oral Amphotericin B
    Vancouver, British Columbia--(Newsfile Corp. - February 25, 2020) - iCo Therapeutics Inc.  (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or "the Company") and its subsidiary, iCo ...
    10.02.20 - Newsfile
    iCo Therapeutics Announces Completion of Phase 1b Oral Amphotericin B Study Dosing and Follow Up
    Vancouver, British Columbia--(Newsfile Corp. - February 10, 2020) - iCo Therapeutics Inc.  (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or "the Company") and its subsidiary, iCo ...
    19.08.19 - DGAP
    iCo Therapeutics Inc. Announces the Issuance of 41,200,000 Units Pursuant to its Non-Brokered Private Placement
    DGAP-News: iCo Therapeutics Inc. / Key word(s): Miscellaneous iCo Therapeutics Inc. Announces the Issuance of 41,200,000 Units Pursuant to its Non-​Brokered Private Placement ...
    07.08.19 - DGAP
    iCo Therapeutics Provides Corporate Update
    DGAP-News: iCo Therapeutics Inc. / Key word(s): Miscellaneous iCo Therapeutics Provides Corporate Update 07.08.2019 / 04:47 The issuer is solely responsible for the content of ...
    28.06.19 - DGAP
    iCo Therapeutics Announces AGM Voting Results
    DGAP-News: iCo Therapeutics Inc. / Key word(s): Miscellaneous iCo Therapeutics Announces AGM Voting Results 28.06.2019 / 14:03 The issuer is solely responsible for the ...
    30.05.19 - DGAP
    iCo Therapeutics Announces First Quarter 2019 Financial Results
    DGAP-News: iCo Therapeutics Inc. / Key word(s): Miscellaneous iCo Therapeutics Announces First Quarter 2019 Financial Results 30.05.2019 / 22:41 The issuer is solely ...
    01.05.19 - DGAP
    iCo Therapeutics Announces 2018 Year End Financial Results
    DGAP-News: iCo Therapeutics Inc. / Key word(s): Miscellaneous iCo Therapeutics Announces 2018 Year End Financial Results 01.05.2019 / 00:39 The issuer is solely responsible ...
    25.02.19 - DGAP
    iCo Therapeutics Inc. Announces the Issuance of 14,400,000 Units Pursuant to its C$1,250,000 Non-Brokered Private Placement
    DGAP-News: iCo Therapeutics Inc. / Key word(s): Miscellaneous iCo Therapeutics Inc. Announces the Issuance of 14,400,000 Units Pursuant to its C$1,250,000 Non-​Brokered ...
    19.02.19 - DGAP
    iCo Therapeutics Inc. Announces Upsizing of Non-Brokered Private Placement to $1,250,000 CDN
    DGAP-News: iCo Therapeutics Inc. / Key word(s): Miscellaneous iCo Therapeutics Inc. Announces Upsizing of Non-​Brokered Private Placement to $1,250,000 CDN 19.02.2019 / ...
    12.02.19 - DGAP
    iCo Therapeutics Inc. Announces the Issuance of 4,000,000 Units Pursuant to its C$750,000 Non-Brokered Private Placement
    DGAP-News: iCo Therapeutics Inc. / Key word(s): Miscellaneous iCo Therapeutics Inc. Announces the Issuance of 4,000,000 Units Pursuant to its C$750,000 Non-​Brokered Private ...
    01.02.19 - DGAP
    iCo Therapeutics Inc. Announces Non-Brokered Private Placement to Raise C$750,000
    DGAP-News: iCo Therapeutics Inc. / Key word(s): Miscellaneous iCo Therapeutics Inc. Announces Non-​Brokered Private Placement to Raise C$750,000 01.02.2019 / 02:07 The ...

    Newssuche

    Videos

    newspaper
    18.04.24
    Technical Trading: Gold mit weiterem Potenzial
    Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »